MX2015012119A - Poliamidas con funcionalidad amina. - Google Patents
Poliamidas con funcionalidad amina.Info
- Publication number
- MX2015012119A MX2015012119A MX2015012119A MX2015012119A MX2015012119A MX 2015012119 A MX2015012119 A MX 2015012119A MX 2015012119 A MX2015012119 A MX 2015012119A MX 2015012119 A MX2015012119 A MX 2015012119A MX 2015012119 A MX2015012119 A MX 2015012119A
- Authority
- MX
- Mexico
- Prior art keywords
- amine functional
- functional polyamides
- infection
- amine
- polyamides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
- C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
- C08G69/26—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from polyamines and polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
- A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/16—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/66—Polyesters containing oxygen in the form of ether groups
- C08G63/668—Polyesters containing oxygen in the form of ether groups derived from polycarboxylic acids and polyhydroxy compounds
- C08G63/672—Dicarboxylic acids and dihydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/02—Polyamines
- C08G73/0273—Polyamines containing heterocyclic moieties in the main chain
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/02—Polyamines
- C08G73/028—Polyamidoamines
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/0622—Polycondensates containing six-membered rings, not condensed with other rings, with nitrogen atoms as the only ring hetero atoms
- C08G73/0627—Polycondensates containing six-membered rings, not condensed with other rings, with nitrogen atoms as the only ring hetero atoms with only one nitrogen atom in the ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polyamides (AREA)
- Hydrogenated Pyridines (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Las poliamidas con funcionalidad amina comprenden grupos amina y amonio a lo largo de la cadena polimérica. Las poliamidas con funcionalidad amina pueden usarse como agentes farmacéuticos y en composiciones farmacéuticas. Las poliamidas con funcionalidad amina son particularmente útiles en el tratamiento o prevención de mucositis e infección, específicamente mucositis oral, infección del sitio quirúrgico e infección pulmonar asociada con fibrosis quística.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361790231P | 2013-03-15 | 2013-03-15 | |
PCT/US2014/022984 WO2014150338A1 (en) | 2013-03-15 | 2014-03-11 | Amine functional polyamides |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015012119A true MX2015012119A (es) | 2016-05-18 |
MX364611B MX364611B (es) | 2019-05-02 |
Family
ID=50390295
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015012119A MX364611B (es) | 2013-03-15 | 2014-03-11 | Poliamidas con funcionalidad amina. |
MX2015013262A MX2015013262A (es) | 2013-03-15 | 2014-03-11 | Composiciones antimicrobianas de poliamida y tratamiento de mastitis. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015013262A MX2015013262A (es) | 2013-03-15 | 2014-03-11 | Composiciones antimicrobianas de poliamida y tratamiento de mastitis. |
Country Status (22)
Country | Link |
---|---|
US (3) | US10131744B2 (es) |
EP (2) | EP2970586B1 (es) |
JP (4) | JP7000021B2 (es) |
KR (2) | KR102233537B1 (es) |
CN (2) | CN105189607B (es) |
AR (1) | AR095366A1 (es) |
AU (2) | AU2014237169B2 (es) |
BR (1) | BR112015022224A2 (es) |
CA (2) | CA2906334C (es) |
CL (1) | CL2015002762A1 (es) |
EA (1) | EA030750B1 (es) |
ES (1) | ES2835382T3 (es) |
HK (2) | HK1215537A1 (es) |
IL (1) | IL241405A0 (es) |
MX (2) | MX364611B (es) |
NZ (1) | NZ712876A (es) |
RU (1) | RU2644554C2 (es) |
SG (1) | SG11201506359UA (es) |
TW (2) | TWI624263B (es) |
UA (1) | UA119642C2 (es) |
WO (2) | WO2014150338A1 (es) |
ZA (1) | ZA201506808B (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014150338A1 (en) | 2013-03-15 | 2014-09-25 | Genzyme Corporation | Amine functional polyamides |
MX2017000447A (es) * | 2014-07-11 | 2017-04-27 | Genzyme Corp | Poliaminas de cadena principal. |
CN104292148A (zh) * | 2014-09-22 | 2015-01-21 | 西南科技大学 | 一种橡胶或树脂光稳定剂的制备方法 |
KR20180029224A (ko) * | 2015-07-09 | 2018-03-20 | 헨켈 아이피 앤드 홀딩 게엠베하 | 저점도 투명 폴리아미드 |
PT3370698T (pt) * | 2015-11-03 | 2022-03-02 | Zoetis Services Llc | Compósitos de polímero sol-gel e utilizações dos mesmos |
MX2018012477A (es) | 2016-04-14 | 2019-03-07 | Merial Inc | Composiciones de multiples dosis que contienen un conservador de poliamida antimicrobiana u octenidina. |
KR20190018317A (ko) * | 2017-08-14 | 2019-02-22 | 한국생명공학연구원 | 모노아세틸디아실글리세롤 화합물을 함유하는 슈도모나스 속 미생물 감염증의 예방 또는 치료용 조성물 |
US10595527B2 (en) | 2017-12-12 | 2020-03-24 | International Business Machines Corporation | Antimicrobial polymers capable of supramolecular assembly |
US10743537B2 (en) | 2017-12-12 | 2020-08-18 | International Business Machines Corporation | Monomer compositions with antimicrobial functionality |
US10667514B2 (en) | 2017-12-12 | 2020-06-02 | International Business Machines Corporation | Antimicrobial ionene compositions with a variety of functional groups |
US10836864B2 (en) | 2017-12-12 | 2020-11-17 | International Business Machines Corporation | Chemical compositions with antimicrobial functionality |
US10653142B2 (en) | 2017-12-12 | 2020-05-19 | International Business Machines Corporation | Polymers with antimicrobial functionalities |
US10687528B2 (en) | 2017-12-12 | 2020-06-23 | International Business Machines Corporation | Antimicrobial polymers with enhanced functionalities |
US10687530B2 (en) | 2017-12-12 | 2020-06-23 | International Business Machines Corporation | Hydrophilic polymers with antimicrobial functionalities |
RU2732206C2 (ru) * | 2018-12-29 | 2020-09-14 | Вероника Андреевна Гусева | Способ лечения маститов у крупного рогатого скота |
KR102052086B1 (ko) * | 2019-07-25 | 2019-12-04 | 복세원 | 젖소 유두 보호제 및 그 제조방법 |
CN111471630B (zh) * | 2020-06-11 | 2021-11-02 | 鲁东大学 | 一株棒杆菌Ytld-phe09及其应用 |
CN114796583B (zh) * | 2022-03-25 | 2023-02-10 | 浙江大学 | 一种基于聚硫辛酸的生物医用贴片材料及其制备方法 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3583946A (en) * | 1969-04-24 | 1971-06-08 | Monsanto Co | Polyureas derived from dipiperidines |
IT981412B (it) * | 1973-03-15 | 1974-10-10 | Montedison Spa | Poliammidi da acidi eterociclici aromatici ortocarbossilici e pro cedimento per prepararle |
US4070400A (en) * | 1975-10-16 | 1978-01-24 | Merck & Co., Inc. | Diphenyl polyamides having a cyclohexylene moiety |
DE2942680C2 (de) * | 1979-10-23 | 1986-02-27 | Schering AG, 1000 Berlin und 4709 Bergkamen | Schmelzkleber auf Basis von Polyesteramiden und deren Verwendung zum Verkleben von organischen und anorganischen Substraten |
JPS591531A (ja) * | 1982-06-25 | 1984-01-06 | Daicel Chem Ind Ltd | 感温性高分子材料 |
JPS596220A (ja) * | 1982-07-01 | 1984-01-13 | Daicel Chem Ind Ltd | 新規ポリアミド共重合体 |
US4462942A (en) * | 1982-07-30 | 1984-07-31 | Eli Lilly And Company | A47934 Antibiotic and process for production thereof |
JPH0228208A (ja) * | 1988-04-28 | 1990-01-30 | Japan Synthetic Rubber Co Ltd | 感放射線性共重合体およびその製造方法 |
JPH03258832A (ja) * | 1990-03-08 | 1991-11-19 | Mitsubishi Kasei Corp | 不飽和ポリアミド |
US6369049B1 (en) * | 1998-04-30 | 2002-04-09 | Eli Lilly And Company | Treatment of mastitis |
US6203812B1 (en) * | 1998-06-29 | 2001-03-20 | Hydromer, Inc. | Hydrophilic polymer blends used to prevent cow skin infections |
AUPP584298A0 (en) * | 1998-09-14 | 1998-10-08 | Starpharma Limited | Antimicrobial and antiparasitic agents |
US20020009491A1 (en) * | 2000-02-14 | 2002-01-24 | Rothbard Jonathan B. | Compositions and methods for enhancing drug delivery across biological membranes and tissues |
PT1395289E (pt) * | 2000-06-08 | 2011-03-16 | Sang Dr Christine | Tratamento da dor neuropática com antagonistas do receptor de n-metil-d-aspartato (nmda) |
DE60127401T2 (de) * | 2000-06-12 | 2008-01-03 | University Of Saskatchewan, Saskatoon | Milchvieh immunisierung mit mig protein |
GB0029004D0 (en) * | 2000-11-28 | 2001-01-10 | Pharmacia & Upjohn Spa | Process for preparing distamycin derivatives |
US20040013698A1 (en) * | 2001-07-09 | 2004-01-22 | Aust Duncan T | Method for preparing topical preparations containing skin protective agents with enhanced barrier properties |
DE102004054873A1 (de) * | 2004-11-12 | 2006-05-18 | Bayer Healthcare Ag | Behandlung von Mastitis |
WO2009111838A1 (en) * | 2008-03-13 | 2009-09-17 | Agriculture Victoria Services Pty Limited | Method of treatment using antimicrobial composition |
EP2138171A1 (en) * | 2008-06-18 | 2009-12-30 | Istituto Superiore Di Sanita' | Veterinarian compositions containing terpinen-4-ol for the treatment and prevention of mastitis |
CA2741667A1 (en) * | 2008-11-07 | 2010-05-14 | Novabay Pharmaceuticals, Inc. | Antimicrobial n-chlorinated compositions |
JP5808082B2 (ja) * | 2010-04-30 | 2015-11-10 | 株式会社Adeka | 細胞への水溶性高分子量物質の導入方法及び導入剤 |
US8758778B2 (en) | 2010-09-16 | 2014-06-24 | The Regents Of The University Of California | Polymeric nano-carriers with a linear dual response mechanism and uses thereof |
CN102653779B (zh) * | 2011-03-04 | 2014-02-19 | 北京科润三联生物技术有限责任公司 | 一种新型重组抗菌多肽药物的制备方法 |
WO2012151555A1 (en) * | 2011-05-04 | 2012-11-08 | President And Fellows Of Harvard College | Methods and coatings for treating biofilms |
CN103957710B (zh) * | 2011-05-16 | 2016-04-20 | 塞尔西优蒂克斯公司 | 用于治疗粘膜炎的化合物 |
WO2014001353A1 (en) | 2012-06-29 | 2014-01-03 | Bayer Animalhealth Gmbh | Pharmaceutical compositions and treatment of mastitis |
WO2014150338A1 (en) | 2013-03-15 | 2014-09-25 | Genzyme Corporation | Amine functional polyamides |
-
2014
- 2014-03-11 WO PCT/US2014/022984 patent/WO2014150338A1/en active Application Filing
- 2014-03-11 BR BR112015022224A patent/BR112015022224A2/pt not_active IP Right Cessation
- 2014-03-11 US US14/204,339 patent/US10131744B2/en active Active
- 2014-03-11 JP JP2016501120A patent/JP7000021B2/ja active Active
- 2014-03-11 NZ NZ712876A patent/NZ712876A/en unknown
- 2014-03-11 RU RU2015144224A patent/RU2644554C2/ru not_active IP Right Cessation
- 2014-03-11 EP EP14713737.6A patent/EP2970586B1/en active Active
- 2014-03-11 ES ES14720740T patent/ES2835382T3/es active Active
- 2014-03-11 JP JP2016501201A patent/JP6359630B2/ja active Active
- 2014-03-11 EP EP14720740.1A patent/EP2968231B1/en active Active
- 2014-03-11 MX MX2015012119A patent/MX364611B/es active IP Right Grant
- 2014-03-11 CA CA2906334A patent/CA2906334C/en active Active
- 2014-03-11 CN CN201480026339.7A patent/CN105189607B/zh active Active
- 2014-03-11 WO PCT/US2014/023299 patent/WO2014150451A1/en active Application Filing
- 2014-03-11 CA CA2907045A patent/CA2907045C/en active Active
- 2014-03-11 CN CN201480023831.9A patent/CN105338976B/zh active Active
- 2014-03-11 KR KR1020157029866A patent/KR102233537B1/ko active IP Right Grant
- 2014-03-11 UA UAA201509974A patent/UA119642C2/uk unknown
- 2014-03-11 AU AU2014237169A patent/AU2014237169B2/en active Active
- 2014-03-11 AU AU2014237232A patent/AU2014237232B9/en active Active
- 2014-03-11 MX MX2015013262A patent/MX2015013262A/es active IP Right Grant
- 2014-03-11 SG SG11201506359UA patent/SG11201506359UA/en unknown
- 2014-03-11 EA EA201591812A patent/EA030750B1/ru unknown
- 2014-03-11 KR KR1020157028805A patent/KR20150132325A/ko not_active Application Discontinuation
- 2014-03-12 AR ARP140100905A patent/AR095366A1/es unknown
- 2014-03-13 TW TW103108906A patent/TWI624263B/zh not_active IP Right Cessation
- 2014-03-14 US US14/210,571 patent/US9326994B2/en active Active
- 2014-03-14 TW TW103109522A patent/TWI667028B/zh active
-
2015
- 2015-09-09 IL IL241405A patent/IL241405A0/en unknown
- 2015-09-14 ZA ZA2015/06808A patent/ZA201506808B/en unknown
- 2015-09-15 CL CL2015002762A patent/CL2015002762A1/es unknown
-
2016
- 2016-03-24 HK HK16103507.2A patent/HK1215537A1/zh unknown
- 2016-03-24 US US15/079,887 patent/US10113032B2/en active Active
- 2016-07-20 HK HK16108615.0A patent/HK1220711A1/zh unknown
-
2018
- 2018-08-01 JP JP2018144725A patent/JP2018188662A/ja active Pending
-
2019
- 2019-11-22 JP JP2019210972A patent/JP2020045493A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX364611B (es) | Poliamidas con funcionalidad amina. | |
CL2016001231A1 (es) | Compuestos de inhibidor de autotaxina | |
MX2017004838A (es) | Composiciones de interleucina-15 y usos de estas. | |
PH12014501738A1 (en) | Piperidino-pyrimidine derivatives for the treatment of viral infections | |
MX362725B (es) | Bacterias probioticas. | |
PH12015500724A1 (en) | 1, 2, 4-triazine derivatives for the treatment of viral infections | |
PH12016500465B1 (en) | Deoxynojirimycin derivatives and methods of their using | |
EA202191513A1 (ru) | Снижение вязкости фармацевтических составов | |
CY1123366T1 (el) | Παραγωγα 8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δeκανιου | |
CY1120098T1 (el) | Συνθεσεις που περιεχουν βορτιοξετινη και δονεπεζιλη | |
MX2017012596A (es) | Una composicion farmaceutica y el uso de la misma. | |
PH12016501371A1 (en) | Pharmaceutical compositions comprising 15-hepe and methods of treating asthma and lung disorders using same | |
BR112015016033A2 (pt) | composições e métodos para tratamento de infecções por bactérias | |
MX2016014699A (es) | (s)-pirlindol o sus sales farmaceuticamente aceptables para uso en medicina. | |
PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
MX2017000447A (es) | Poliaminas de cadena principal. | |
TR201905218T4 (tr) | Nörodejenerati̇f hastaliklarin tedavi̇si̇ i̇çi̇n yararli vi̇tanoli̇dler. | |
WO2014197536A3 (en) | Novel beta lactams as modulators of glutamate uptake and methods for use thereof | |
WO2017079403A3 (en) | Polymeric nanoparticles | |
CY1118117T1 (el) | Νεα αμινο-πυρρολινικα παραγωγα και η χρηση τους στην προληψη ή και τη θεραπεια του μεταβολικου συνδρομου | |
MX2016003230A (es) | Complejo lubricante para la boca. | |
MX2021001361A (es) | Composicion liquida de fibrinogeno humano. | |
MX360040B (es) | Nuevo agente antibacteriano derivado de florfenicol unido a sulfoximina y el uso del mismo en el tratamiento de infecciones bacterianas en ganado vacuno. | |
TN2014000484A1 (en) | Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis. | |
UA101533U (uk) | Полівалентний оральний гель для лікування і профілактики післяімплантаційних ускладнень |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |